Hoey Investments Inc. Takes $70,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

Hoey Investments Inc. purchased a new position in iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 530 shares of the financial services provider’s stock, valued at approximately $70,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Edmond DE Rothschild Holding S.A. increased its stake in iShares Biotechnology ETF by 636.3% during the 4th quarter. Edmond DE Rothschild Holding S.A. now owns 5,890 shares of the financial services provider’s stock valued at $779,000 after purchasing an additional 5,090 shares in the last quarter. O Shaughnessy Asset Management LLC increased its position in shares of iShares Biotechnology ETF by 10.8% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 2,745 shares of the financial services provider’s stock valued at $363,000 after acquiring an additional 267 shares in the last quarter. CIBC Private Wealth Group LLC raised its holdings in iShares Biotechnology ETF by 2.8% in the 4th quarter. CIBC Private Wealth Group LLC now owns 13,628 shares of the financial services provider’s stock worth $1,837,000 after acquiring an additional 375 shares during the last quarter. LM Advisors LLC lifted its position in iShares Biotechnology ETF by 3.7% in the 4th quarter. LM Advisors LLC now owns 6,919 shares of the financial services provider’s stock valued at $915,000 after acquiring an additional 245 shares in the last quarter. Finally, Murphy & Mullick Capital Management Corp purchased a new stake in iShares Biotechnology ETF during the 4th quarter valued at $35,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 1.0 %

iShares Biotechnology ETF stock opened at $130.29 on Monday. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The stock has a fifty day simple moving average of $136.16 and a two-hundred day simple moving average of $138.87. The firm has a market cap of $6.16 billion, a price-to-earnings ratio of 27.83 and a beta of 0.84.

iShares Biotechnology ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th were given a $0.1212 dividend. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date was Tuesday, March 18th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.